ARTICLE | Company News
Isis Pharmaceuticals, Abbott deal
March 5, 2001 8:00 AM UTC
ISIP’s GeneTrove division and ABT extended for two years their 1999 collaboration that uses GeneTrove’s antisense technology to assist ABT in determining the function and therapeutic relevance of gene...